Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. The large number of journeys and participation in events have enabled him to build up a personal network.
As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders. Besides precious metals and energy sources, innovations from various industries are of particular interest.
Since the 1990s, extensive experience in the capital market from various perspectives has been gained. The anecdotes from this time are now paired with the expert knowledge from his business studies in the current commentaries in an entertaining way.
Commented by Mario Hose
Commented by Mario Hose on September 12th, 2022 | 10:30 CEST
JinkoSolar, TubeSolar, Nel ASA - The innovations of the future
Less coal, more sun! In order to reduce the emission of greenhouse gases into the atmosphere, the share of renewable energy sources in Germany's gross electricity consumption is to increase to 65% by 2030. Instead of fossil fuels, more renewable energy sources are to serve as the basis for electricity production. In addition to the expansion of wind power plants at sea and on land, the German government is also pushing ahead with energy generation from solar plants. The transformation in the energy industry is creating new technology companies that could have significant potential and a bright future due to their innovation.
Read
Commented by Mario Hose on August 25th, 2022 | 05:07 CEST
dynaCERT CEO Jim Payne on carbon credits and VERRA
The Canadian hydrogen company dynaCERT is focused on the development of scalable technologies. In cooperation with VERRA in the USA, a process is currently being developed to certify the savings in energy consumption resulting from the use of dynaCERT products as Carbon Credits in the future. The market is large, so the trade fair 'IAA TRANSPORTATION' in Hannover, Germany, September 20-25, 2022, is eagerly awaited for where the company will make its presence clear. dynaCERT was significantly impacted by Corona lockdowns and has been rallying for the past few days, heading towards pre-Covid-19 pandemic levels, peaking at CAD 1.25. In Canada, more than 6.3 million shares were traded yesterday and at the close of the market, another 1.89 million shares were in the bid at CAD 0.30. CEO Jim Payne told us what the significance of the successful deal with VERRA will be. A taste of what to expect.
Read
Commented by Mario Hose on August 18th, 2022 | 10:28 CEST
Defence Therapeutics CEO Sébastien Plouffe on the next steps in the battle against cancer
A publicly traded biotechnology business called Defence Therapeutics is developing new vaccines and antibody-drug conjugates (ADC) products on its own proprietary platform. The ACCUM technology, which enables precise delivery of vaccine antigens or ADCs in their intact form to target cells, forms the basis of Defence Therapeutics' platform. As a result, catastrophic illnesses like cancer and infectious diseases can be combated with greater efficacy and potency. CEO Sébastien Plouffe gives us background on the company's latest development in the battle against cancer.
Read
Commented by Mario Hose on August 16th, 2022 | 07:08 CEST
Kodiak Copper CEO Claudia Tornquist: The long-term picture for copper remains extremely strong
Copper is one of the important metals in modern life. When it comes to the energy transition and the change in mobility, the red metal is of great importance. In the global competition between industrial market players, access and price therefore play an important role. Raw material nations such as Canada supply the market with the ingredient of countless technical devices, which are often produced in the Middle Kingdom. For this reason, it is particularly interesting to hear the opinion of an expert. Claudia Tornquist is the CEO of Kodiak Copper Corp. and is exploring for new copper deposits in British Columbia.
Read
Commented by Mario Hose on August 2nd, 2022 | 10:57 CEST
Defence Therapeutics VP Research + Development Dr. Moutih Rafei on the next generation oncology-targeting therapies
The publicly traded biotechnology company called Defence Therapeutics is developing new vaccines and ADC products on its own proprietary platform. The Accum technology, which enables precise delivery of vaccine antigens or ADCs in their intact form to target cells, forms the basis of Defence Therapeutics' platform. As a result, catastrophic illnesses like cancer and infectious diseases can be combated with greater efficacy and potency.
Read
Commented by Mario Hose on August 1st, 2022 | 06:00 CEST
Desert Gold Ventures CEO Jared Scharf on gold as a hedge against inflation
As the European Central Bank raised its interest rate by 50 basis points on July 21 in line with the U.S. Fed and the Bank of England, the price of gold in the London Bullion Market Association fell to USD 1,700 per ounce. Recession danger is rising as more rate increases are anticipated. Changing consumer and equity market conditions are reflected in declining physical and exchange-traded fund demand for gold. Desert Gold Ventures CEO Jared Scharf explains us his view.
Read
Commented by Mario Hose on July 28th, 2022 | 05:30 CEST
Almonty Industries CEO Lewis Black on the global dependence on China
Lewis Black is the CEO of Almonty Industries and has over 15 years of experience in the mining industry. The company is specialized in acquiring operations and assets in tungsten markets. Tungsten is one of the critical raw materials and with this in mind, Almonty's work is of importance to many different processing industries around the globe. In the current tense situation in connection with supply chain issues and sanctions as well as environmental protection requirements, the company is increasingly coming into focus.
Read
Commented by Mario Hose on July 26th, 2022 | 09:54 CEST
Enapter CEO Sebastian-Justus Schmidt exclusively on the offer in the current energy situation in Germany
Sebastian-Justus Schmidt founded Enapter to build green energy systems where there is a financial advantage over fossil fuel use in the medium term. He is sure that future-oriented companies need application-oriented, effective research and development with intensive software support as a foundation.
Read
Commented by Mario Hose on January 20th, 2022 | 11:08 CET
Cardiol, Novavax, Valneva - Why it's worth buying now!
The trading week is coming to an end and on Thursday the German benchmark index DAX continues to trade below the psychological mark of 16,000 points at a level of 15,785 points and an increase of 0.10%. The rest of today and Friday remain to make a jump. It will probably depend on the guidance from the U.S., but at the hour, U.S. futures are all green. MDAX last traded at 34,135 points (+0.07%), TecDAX at 3,544 points (+0.07%) and SDAX at 15,626 points up 0.33%. Companies from the biotech sector are again in the focus of the investors today.
Read
Commented by Mario Hose on January 19th, 2022 | 14:51 CET
Trading shares in focus: BrainChip, Gazprom, Saturn Oil + Gas
The German indices have reached on the second day of the week after a bumpy start to trading now again positive signs. The German benchmark index DAX traded at a level of 15,824 points and thus around 0.28% in the plus, in the daily low has held the mark of 15,600 points and since then goes upwards. The MDAX last traded at 34,172 points (+0.05%), TexDAX at 3,532 points (+1.28%) and SDAX at 15,613 points with 0.03% up. Exciting individual stocks offer interesting investment opportunities.
Read